Celldex Therapeutics (CLDX) Amortization - Intangibles (2010 - 2018)
Celldex Therapeutics (CLDX) posted quarterly Amortization - Intangibles of $224000.0 for Q1 2018, little changed year-over-year from $224000.0 in Q1 2017, and little changed quarter-over-quarter from $224000.0 in Q4 2017.
Celldex Therapeutics (CLDX) Amortization - Intangibles (2010 - 2018) Analysis & Trends
Celldex Therapeutics' Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $224000.0 for Q1 2018.
- In Q1 2018, Amortization - Intangibles changed 0.0% year-over-year to $224000.0; the TTM figure through Dec 2018 stood at $224000.0 (down 75.0% YoY), while the FY2018 annual figure was $224000.0, down 75.0% from the prior year.
- Amortization - Intangibles for Q1 2018 stood at $224000.0, roughly flat from $224000.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $254000.0 in Q2 2014, with the low at $224000.0 in Q1 2017.
- The 5-year median for Amortization - Intangibles is $253000.0 (2014), against an average of $243882.4.
- The sharpest annual moves came in 2014 and 2017: Amortization - Intangibles changed 0.0% in 2014, then decreased 11.81% in 2017.
- Celldex Therapeutics' Amortization - Intangibles stood at $253000.0 in 2014, then changed by 0.0% to $253000.0 in 2015, then retreated by 6.32% to $237000.0 in 2016, then dropped by 5.49% to $224000.0 in 2017, then changed by 0.0% to $224000.0 in 2018.
- Business Quant data shows CLDX's Amortization - Intangibles at $224000.0 in Q1 2018, $224000.0 in Q4 2017, and $224000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 224,000.00 |
| Dec 31, 2017 | 224,000.00 |
| Sep 30, 2017 | 224,000.00 |
| Jun 30, 2017 | 224,000.00 |
| Mar 31, 2017 | 224,000.00 |
| Dec 31, 2016 | 237,000.00 |
| Sep 30, 2016 | 254,000.00 |
| Jun 30, 2016 | 254,000.00 |
| Mar 31, 2016 | 253,000.00 |
| Dec 31, 2015 | 253,000.00 |
| Sep 30, 2015 | 254,000.00 |
| Jun 30, 2015 | 254,000.00 |
| Mar 31, 2015 | 253,000.00 |
| Dec 31, 2014 | 253,000.00 |
| Sep 30, 2014 | 254,000.00 |
| Jun 30, 2014 | 254,000.00 |
| Mar 31, 2014 | 253,000.00 |
| Dec 31, 2013 | 253,000.00 |
| Sep 30, 2013 | 254,000.00 |
| Jun 30, 2013 | 254,000.00 |